New wonder weight-loss drug. Don’t worry about the cancer

13 by / on 13 Feb 2015, / in weight loss

Liraglutide hit the headlines in January because it had just been approved by the European Medicines Agency (EMA) for the treatment of obesity, to be marketed as “Saxenda”. The EMA had previously approved it for type 2 diabetes in July 2009. In America the approval for obesity had come a month earlier in December 2014.